Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CCR5 | P51681 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26130986 | 0.92 | CCR1 (0.60) | CCR1RAB9ACCR5KDM4EALDH1A1 | |
| SCHEMBL31191929 | 0.92 | CCR1 (0.60) | CCR1RAB9ACCR5KDM4EALDH1A1 | |
| SCHEMBL4586663 | 0.83 | CCR1 (0.60) | CCR1RAB9ACCR5KDM4EALDH1A1 | |
| SCHEMBL7219924 | 0.81 | TP53 (0.54) | RAB9AKDM4EALDH1A1KMT2AMEN1 | |
| SCHEMBL1563032 | 0.78 | METAP2 (0.55) | KDM4EKMT2AMEN1MAPTL3MBTL1 | |
| SCHEMBL11626595 | 0.78 | KDM4E (0.69) | RAB9AKDM4EALDH1A1KMT2AMEN1 | |
| SCHEMBL16506398 | 0.78 | KDM4E (0.42) | KDM4EKMT2AMEN1MAPTL3MBTL1 | |
| SCHEMBL30018810 | 0.76 | ALDH1A1 (0.43) | KDM4EALDH1A1KMT2AMEN1MAPT | |
| SCHEMBL1563307 | 0.76 | GFER (0.50) | RAB9AKDM4EALDH1A1MAPTGAA | |
| Broquinaldol SCHEMBL29606314 | 0.76 | MAPT (0.54) | CCR1RAB9ACCR5KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117447516-A | 4-pyridyl modified copper (I) metal complex and preparation method and application thereof | 中山大学 | 2024-01-26 | — | — | CN | disclosed |
| US-11839154-B2 | Phenanthroline-based compound and optoelectronic device comprising the same | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY | 2023-12-05 | — | — | US | disclosed |
| US-11839154-B2 | Phenanthroline-based compound and optoelectronic device comprising the same | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY | 2023-12-05 | — | — | US | disclosed |
| US-11839154-B2 | Phenanthroline-based compound and optoelectronic device comprising the same | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY | 2023-12-05 | — | — | US | disclosed |
| US-20230255108-A1 | NOVEL PHENANTHROLINE-BASED COMPOUND AND OPTOELECTRONIC DEVICE COMPRISING THE SAME | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-08-10 | — | — | US | disclosed |
| US-20230255108-A1 | NOVEL PHENANTHROLINE-BASED COMPOUND AND OPTOELECTRONIC DEVICE COMPRISING THE SAME | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-08-10 | — | — | US | disclosed |
| US-20230255108-A1 | NOVEL PHENANTHROLINE-BASED COMPOUND AND OPTOELECTRONIC DEVICE COMPRISING THE SAME | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-08-10 | — | — | US | disclosed |
| EP-4223744-A1 | NOVEL PHENANTHROLINE-BASED COMPOUND AND OPTOELECTRONIC DEVICE COMPRISING THE SAME | Gwangju Institute of Science and Technology (KR) | 2023-08-09 | — | — | EP | disclosed |
| EP-4223744-A1 | NOVEL PHENANTHROLINE-BASED COMPOUND AND OPTOELECTRONIC DEVICE COMPRISING THE SAME | Gwangju Institute of Science and Technology (KR) | 2023-08-09 | — | — | EP | disclosed |
| EP-2595997-B1 | COPPER(I) COMPLEXES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2015-09-16 | — | — | EP | disclosed |
| EP-2595997-B1 | COPPER(I) COMPLEXES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2015-09-16 | — | — | EP | disclosed |
| US-9024026-B2 | Copper (I) complexes for optoelectronic devices | CYNORA GMBH (DE) | 2015-05-05 | — | — | US | disclosed |
| US-9024026-B2 | Copper (I) complexes for optoelectronic devices | CYNORA GMBH (DE) | 2015-05-05 | — | — | US | disclosed |
| US-9024026-B2 | Copper (I) complexes for optoelectronic devices | CYNORA GMBH (DE) | 2015-05-05 | — | — | US | disclosed |
| US-20130150581-A1 | COPPER (I) COMPLEXES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2013-06-13 | — | — | US | disclosed |
| US-20130150581-A1 | COPPER (I) COMPLEXES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2013-06-13 | — | — | US | disclosed |
| US-20130150581-A1 | COPPER (I) COMPLEXES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2013-06-13 | — | — | US | disclosed |
| EP-2595997-A1 | COPPER (I) COMPLEXES FOR OPTOELECTRONIC DEVICES | Cynora GmbH (DE) | 2013-05-29 | — | — | EP | disclosed |
| WO-2012010650-A1 | COPPER (I) COMPLEXES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2012-01-26 | — | — | WO | disclosed |
| WO-2012010650-A1 | COPPER (I) COMPLEXES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2012-01-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11839154-B2 | Phenanthroline-based compound and optoelectronic device comprising the same | PAH, PPOX, HCN2 | CCR1 2972/4885RAB9A 1965/4885CCR5 2095/4885 |
| US-20230255108-A1 | NOVEL PHENANTHROLINE-BASED COMPOUND AND OPTOELECTRONIC DEVICE COMPRISING THE SAME | PAH, PPOX, ODC1 | CCR1 2613/4885RAB9A 1650/4885CCR5 1900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.